Business · 16/04/2024
FDA Establishes Center for Clinical Trial Innovation to Enhance Drug Development
The FDA is launching the Center for Clinical Trial Innovation (C3TI) to improve the quality and efficiency of drug development and regulatory decision making, with a focus on innovative approaches to clinical trials.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →